Results 161 to 170 of about 5,003 (295)

Efficacy of erythroid‐stimulating agent and luspatercept in VEXAS syndrome: A multicenter retrospective study by the FRENVEX group

open access: yes
HemaSphere, Volume 9, Issue 6, June 2025.
Maël Heiblig   +13 more
wiley   +1 more source

Machine learning‐based prediction of bleeding risk in extracorporeal membrane oxygenation patients using transfusion as a surrogate marker

open access: yesTransfusion, Volume 65, Issue 6, Page 1051-1060, June 2025.
Abstract Background The increasing use of extracorporeal membrane oxygenation (ECMO) has highlighted challenges in managing bleeding complications. Optimal transfusion strategies remain uncertain for this diverse patient group, necessitating accurate predictive tools.
Tadashi Kamio   +6 more
wiley   +1 more source

Differences in the product characteristics and clinical use of granulocytes for transfusion: The BEST Collaborative study

open access: yesTransfusion, Volume 65, Issue 6, Page 1111-1123, June 2025.
Abstract Background Whether granulocytes for transfusion are beneficial remains uncertain, although some evidence suggests that efficacy may be dose‐related. Granulocytes are mostly produced by apheresis procedure, but other means of production are increasingly used.
Lorna Cain   +28 more
wiley   +1 more source

Rerationship between non-hemolytic-, non-febrile-transfusion reactions and platelet refractoriness in HLA-, and HPA-matched platelet transfusion.

open access: bronze, 1994
Hiroyasu Yasuda   +6 more
openalex   +2 more sources

Vesiculation as potential novel pathogenic mechanism in autoimmune hemolytic anemia

open access: yesTransfusion, Volume 65, Issue 6, Page 1132-1144, June 2025.
Abstract Background Autoimmune hemolytic anemia (AIHA) is typically mediated by immunoglobulin G (IgG) or immunoglobulin M (IgM) antibodies, and more rarely by immunoglobulin A (IgA). The mechanism of red blood cell (RBC) destruction in IgA‐mediated AIHA is not well understood.
Esther C. W. de Boer   +14 more
wiley   +1 more source

Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients [PDF]

open access: yes, 2017
Haas, M. (Masja) de   +5 more
core   +1 more source

LABRAD : Vol 40, Issue 2 - November 2014 [PDF]

open access: yes, 2014
Significance of HLA Typing in Transplant Medicine Role of Protocol Renal Biopsies in Transplant Patients Blood Product Utilization in Haematopoietic Stem Cell Transplant Recipients Use of Magic Marker “C4d” in the Diagnosis of Acute Antibody Mediated ...
Aga Khan University Hospital, Karachi
core   +1 more source

Platelet transfusion refractoriness: how do I diagnose and manage? [PDF]

open access: yesHematology Am Soc Hematol Educ Program, 2020
Cohn CS.
europepmc   +1 more source

The mechanisms of leukocyte removal by filtration [PDF]

open access: yes, 1995
Absolom   +249 more
core   +2 more sources

Effect of HLA Bw4/Bw6 compatibility on platelet transfusion responses of refractory thrombocytopenic patients [PDF]

open access: bronze, 1982
MC McElligott   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy